Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 ShsJohnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 ShsJohnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs

Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs

No trades
See on Supercharts

Key facts today


Johnson & Johnson reported a 100% response rate for its TECVAYLI® and DARZALEX FASPRO® treatment in transplant-eligible multiple myeloma patients, with no serious adverse events.
Johnson & Johnson's Nipocalimab drug received a positive opinion from the CHMP for treating antibody-positive patients with generalized myasthenia gravis, boosting its market potential.
Analyze the impactAnalyze the impact
Market capitalization
‪419.44 B‬USD
0.55USD
‪12.49 B‬USD
‪78.89 B‬USD
Beta (1Y)
−0.02

About Johnson & Johnson


CEO
Joaquin Duato
Website
Headquarters
New Brunswick
Founded
1887
ISIN
ARDEUT110236
FIGI
BBG000FT0KG7
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Check out other big names from the same industry as JNJD.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US478160CM4
Johnson & Johnson 3.5% 15-JAN-2048
Yield to maturity
5.16%
Maturity date
Jan 15, 2048
JNJJ
Johnson & Johnson 3.75% 03-MAR-2047
Yield to maturity
5.14%
Maturity date
Mar 3, 2047
US478160CX0
Johnson & Johnson 5.25% 01-JUN-2054
Yield to maturity
5.13%
Maturity date
Jun 1, 2054
US478160BV5
Johnson & Johnson 3.7% 01-MAR-2046
Yield to maturity
5.12%
Maturity date
Mar 1, 2046
US478160CS1
Johnson & Johnson 2.25% 01-SEP-2050
Yield to maturity
5.10%
Maturity date
Sep 1, 2050
US478160CT9
Johnson & Johnson 2.45% 01-SEP-2060
Yield to maturity
5.08%
Maturity date
Sep 1, 2060
US478160BA1
Johnson & Johnson 4.85% 15-MAY-2041
Yield to maturity
4.91%
Maturity date
May 15, 2041
US478160CR3
Johnson & Johnson 2.1% 01-SEP-2040
Yield to maturity
4.89%
Maturity date
Sep 1, 2040
JNJ4077469
Johnson & Johnson 4.5% 05-DEC-2043
Yield to maturity
4.89%
Maturity date
Dec 5, 2043
JNJ.GT
Johnson & Johnson 4.5% 01-SEP-2040
Yield to maturity
4.73%
Maturity date
Sep 1, 2040
US478160CL6
Johnson & Johnson 3.4% 15-JAN-2038
Yield to maturity
4.69%
Maturity date
Jan 15, 2038

See all JNJD bonds